On May 12, 2025, Shineco Inc. completed a share transaction involving the acquisition of 75% of the equity interests in FuWang (HK) International Company Limited from Yi Yang, the sole shareholder. In exchange, Shineco Life Science, a subsidiary of Shineco Inc., paid RMB 63.89 million (approximately US$8.9 million) in cash and issued 3,400,000 shares of the Company's common stock. The transaction was conducted under Rule 902 of Regulation S of the Securities Act of 1933.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.